Sulfacetamide - Bradley

Drug Profile

Sulfacetamide - Bradley

Alternative Names: 10% sulfacetamide sodium; Carmol Scalp Treatment Lotion; Sulfacetamide sodium

Latest Information Update: 22 Feb 2008

Price : *
* Final gross price and currency may vary according to local VAT and billing address.

At a glance

  • Originator Bradley Pharmaceuticals
  • Class Antibacterials; Sulfonamides
  • Mechanism of Action Undefined mechanism
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.


Highest Development Phases

  • Marketed Seborrhoeic dermatitis

Most Recent Events

  • 21 Feb 2008 Bradley Pharmaceuticals has been acquired by Nycomed US
  • 20 Feb 2001 A study has been added to the Skin Disorders therapeutic trials section
  • 15 Feb 2001 Clinical in Seborrhoeic dermatitis in USA (Topical)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top